No Data
No Data
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Barclays Maintains Danaher(DHR.US) With Hold Rating, Maintains Target Price $270
FDA Approves Danaher Unit's Rapid Test for Hepatitis C
FDA Grants Marketing Authorization To Cepheid For Xpert HCV Test And GeneXpert Xpress System, First Point-Of-Care Hepatitis C Test
Danaher To Go Ex-Dividend On June 28th, 2024 With 0.27 USD Dividend Per Share
Did Danaher Corporation (DHR) Get a Good Analyst Rating for Its Q1 Performance?